GÜL, F. Et Al. 2022. A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM)). FRONTIERS IN IMMUNOLOGY , vol.13 .

GÜL, F., GÖNEN, Z. B., Jones, O. Y., Taşlı, N. P., ZARARSIZ, G., ÜNAL, E., ... ÖZDARENDELİ, A.(2022). A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM)). FRONTIERS IN IMMUNOLOGY , vol.13.

GÜL, FETHİ Et Al. "A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM))," FRONTIERS IN IMMUNOLOGY , vol.13, 2022

GÜL, FETHİ Et Al. "A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM))." FRONTIERS IN IMMUNOLOGY , vol.13, 2022

GÜL, F. Et Al. (2022) . "A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM))." FRONTIERS IN IMMUNOLOGY , vol.13.

@article{article, author={FETHİ GÜL Et Al. }, title={A pilot study for treatment of severe COVID-19 pneumonia by aerosolized formulation of convalescent human immune plasma exosomes (ChipEXO (TM))}, journal={FRONTIERS IN IMMUNOLOGY}, year=2022}